Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01533974 · ClinicalTrials.gov registry record · Phase 1
PATH Partnering to Achieve Tobacco-free Health
A Phase 1 study, sponsored by Fred Hutchinson Cancer Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 450
- Enrollment target
NCT01533974: Completed Phase 1 study, sponsored by Fred Hutchinson Cancer Center.
NCT01533974 is a Phase 1 study that has completed, run by Fred Hutchinson Cancer Center. The registered enrollment target is 450 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (650% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01533974, a Phase 1 study, has completed, sponsored by Fred Hutchinson Cancer Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 450 participants
- Enrollment target
Study Summary
The overall aim of this 5-year project is to capitalize on the strong theoretical and promising empirical evidence for Acceptance \& Commitment Therapy (ACT) as an intervention for smoking cessation by comparing the effectiveness of ACT against standard cognitive behavioral therapy (CBT) counseling when both are offered with nicotine replacement therapy (NRT) and delivered within a real world healthcare setting.
Primary Outcome
30 day point prevalence abstinence at 12 months. Missing = smoking and self report.
Interventions
- OTHER Cognitive Behavioral Therapy (CBT)
- OTHER Acceptance & Commitment Therapy (ACT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450 participants |
| Start Date | 2011-06 |
| Est. Completion | 2015-01 |
| Phase | Phase 1 |
What the finished NCT01533974 record still lists
NCT01533974 is an interventional study that assigns participants to a tested intervention. The registered 450 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (650% higher).
The record links to 0 conditions, and to 2 interventions - of which Cognitive Behavioral Therapy (CBT) is the first listed.
NCT01533974 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01533974 about?
NCT01533974 is a clinical study titled "PATH Partnering to Achieve Tobacco-free Health". The overall aim of this 5-year project is to capitalize on the strong theoretical and promising empirical evidence for Acceptance \& Commitment Therapy (ACT) as an intervention for smoking cessation by comparing the effectiveness of ACT against standard cognitive behavioral therapy (CBT) counseling ...
What is the current status of trial NCT01533974?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 450 participants. The study started on 2011-06. Estimated completion is 2015-01.
What interventions are being tested in trial NCT01533974?
The interventions under investigation include: Cognitive Behavioral Therapy (CBT) (OTHER), Acceptance & Commitment Therapy (ACT) (OTHER).
Who is sponsoring clinical trial NCT01533974?
This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01533974's enrollment target sits among peer trials
450 54th of 2000 higher than 1,944 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00515060 · 450 participants
Psychophysical Studies of Cancer Therapy Pain
- NCT01257269 · 450 participants
Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
- NCT03047161 · 450 participants
Electrophysiology of Fetal Arrhythmia
- NCT03269630 · 450 participants
New Orleans Pulmonary Hypertension Biobank
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia